collage of HPRU2 members

Understanding the underlying causes of AMR and HCAI, identifying the best methods to improve antimicrobial use, their potential impact and their cost-effectiveness

The Unit is a partnership between Imperial College and UK Health Security Agency.  It has been funded by NIHR for a further five-year term from 1 April 2020 and builds on an existing critical mass of research conducted between 01 April 2014 - 31 March 2020.

The Unit’s Director is Professor Alison Holmes and its UK-HSA lead is Matt Ellington. Find out more about our people here.

The Unit’s current partners are: 

ICHP logo

warwick logo

CAM updated

About us

The National Institute for Health Research (NIHR) has funded the development of a number of Health Protection Research Units (HPRU) in key priority areas. These research units are collaborations between Universities, UK Health Security Agency (UK-HSA) and other partner organisations and aim to provide centres of excellence in multi-disciplinary health protection research.

The NIHR HPRU in Healthcare Associated Infections (HCAI) and Antimicrobial Resistance (AMR) at Imperial College London, started on 1 April 2014 and has now renewed five-year funding from 1 April 2020. 

Our HPRU recognises the different skills required to address the threat of AMR and HCAIs, and it brings together researchers from a range of disciplines and professions (including doctors, engineers, epidemiologists, microbiolosts, pharmacists, behavioural scientists, economists, and nurses). Our approach to addressing HCAIs and AMR is via four complementary themes:

  1. Priority pathogens
  2. Precision prescribing
  3. Practice, design and engineering
  4. Population health and policy